Business Wire

BioTrace Medical Announces FDA Clearance of Innovative Temporary Pacing Technology for Transcatheter Aortic Valve Procedures and Other Cardiovascular Applications

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Tempo ® Lead, an innovative temporary pacing lead ...
TCTMD

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

MENLO PARK, Calif.-BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in ...
Yahoo Finance

SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance

SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- Solo Pace Incorporated, an emerging medical technology company, today announced the commercial release of the SoloPace FUSION™ Temporary Pacing System.
Morningstar

SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance

New temporary pacing system is designed to improve patient safety, reduce costs, and enhance efficiency for transcatheter heart valve (THV) procedures. SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- ...